Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease.
Само за регистроване кориснике
2015
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
Pharmacotherapy, 2015, 35, 5, e66-e66Издавач:
- Wiley-Blackwell, Hoboken
Напомена:
- American College of Clinical Pharmacy 2015, Virtual Poster Symposium
Институција/група
PharmacyTY - CONF AU - Kovačević, Milena AU - Miljković, Branislava AU - Vezmar-Kovačević, Sandra AU - Radovanović, Slavica PY - 2015 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2451 PB - Wiley-Blackwell, Hoboken C3 - Pharmacotherapy T1 - Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease. VL - 35 IS - 5 SP - e66 EP - e66 DO - 10.1002/phar.1606 ER -
@conference{ author = "Kovačević, Milena and Miljković, Branislava and Vezmar-Kovačević, Sandra and Radovanović, Slavica", year = "2015", publisher = "Wiley-Blackwell, Hoboken", journal = "Pharmacotherapy", title = "Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease.", volume = "35", number = "5", pages = "e66-e66", doi = "10.1002/phar.1606" }
Kovačević, M., Miljković, B., Vezmar-Kovačević, S.,& Radovanović, S.. (2015). Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease.. in Pharmacotherapy Wiley-Blackwell, Hoboken., 35(5), e66-e66. https://doi.org/10.1002/phar.1606
Kovačević M, Miljković B, Vezmar-Kovačević S, Radovanović S. Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease.. in Pharmacotherapy. 2015;35(5):e66-e66. doi:10.1002/phar.1606 .
Kovačević, Milena, Miljković, Branislava, Vezmar-Kovačević, Sandra, Radovanović, Slavica, "Drug-drug interactions assessment: potential to improve therapy outcomes in elderly Serbian patients with cardiovascular disease." in Pharmacotherapy, 35, no. 5 (2015):e66-e66, https://doi.org/10.1002/phar.1606 . .